Evidence map›Paper›PMID 36267693›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2022

Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal Antibodies.

Matthaios Papadimitriou-Olivgeris, Ana Cipriano, Nicolas Guggisberg, Marie Kroemer, Jonathan Tschopp, Oriol Manuel, Dela Golshayan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Matthaios Papadimitriou-OlivgerisInfectious Diseases Service, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Ana CiprianoInfectious Diseases Service, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Nicolas GuggisbergTransplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Marie KroemerPharmacy Department, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Jonathan TschoppInfectious Diseases Service, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Oriol ManuelInfectious Diseases Service, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Dela GolshayanTransplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
University of Lausanne · CHLausanne Natation · CHService de la Santé Publique · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kidney transplant recipients (KTR) are at increased risk for COVID-19-associated complications. We aimed to describe the evolving epidemiology and outcome of PCR-documented SARS-CoV-2 infection in KTR followed at our institution from March 2020 to May 2022. The primary endpoint was hospitalization for COVID-19-related symptoms or death within 28 days from diagnosis. Overall, 243 cases were included of which 68 (28%) developed the primary outcome. A significant decrease in the incidence of the primary outcome was observed (

Indexed as

COVID-19Kidney TransplantationAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeutralizingAntibodies, ViralHumansSARS-CoV-2Spike Glycoprotein, CoronavirusTransplant RecipientsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, NeutralizingAntibodies, ViralcasirivimabimdevimabsotrovimabSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19kidney transplantationmonoclonal antibodiesoutcomeSARS-CoV-2vaccination

Identifiers

PMID36267693
PMCPMC9576844
OpenAlexW4301398377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.